1. Home
  2. SOPA vs ENSC Comparison

SOPA vs ENSC Comparison

Compare SOPA & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Society Pass Incorporated

SOPA

Society Pass Incorporated

SELL

Current Price

$3.14

Market Cap

6.5M

Sector

Technology

ML Signal

SELL

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$1.01

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPA
ENSC
Founded
2018
2003
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPA
ENSC
Price
$3.14
$1.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
13.6M
448.3K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,227,427.00
$4,487,973.00
Revenue This Year
$26.32
N/A
Revenue Next Year
$13.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.65
1.51
52 Week Low
$0.64
$0.86
52 Week High
$6.75
$9.31

Technical Indicators

Market Signals
Indicator
SOPA
ENSC
Relative Strength Index (RSI) 61.94 31.81
Support Level $2.41 $0.89
Resistance Level $4.46 $1.24
Average True Range (ATR) 0.67 0.09
MACD 0.21 0.01
Stochastic Oscillator 61.03 34.13

Price Performance

Historical Comparison
SOPA
ENSC

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: